Literature DB >> 8796343

Insulin receptors in breast cancer: biological and clinical role.

V Papa1, A Belfiore.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8796343     DOI： 10.1007/BF03347871

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  53 in total

Review 1.  Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations.

Authors:  W H Daughaday; P Rotwein
Journal:  Endocr Rev       Date:  1989-02       Impact factor: 19.871

2.  Overexpression of the human insulinlike growth factor I receptor promotes ligand-dependent neoplastic transformation.

Authors:  M Kaleko; W J Rutter; A D Miller
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

Review 3.  Hybrid insulin receptors. Molecular mechanisms of negative-dominant mutations in receptor-mediated insulin resistance.

Authors:  J Whittaker; M A Soos; K Siddle
Journal:  Diabetes Care       Date:  1990-06       Impact factor: 19.112

4.  Human insulin receptor radioimmunoassay: applicability to insulin-resistant states.

Authors:  V Pezzino; V Papa; V Trischitta; A Brunetti; P A Goodman; M K Treutelaar; J A Williams; B A Maddux; R Vigneri; I D Goldfine
Journal:  Am J Physiol       Date:  1989-09

5.  Influence of insulin administration on growth of the 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in intact, oophorectomized, and hypophysectomized rats.

Authors:  J C Heuson; N Legros; R Heimann
Journal:  Cancer Res       Date:  1972-02       Impact factor: 12.701

Review 6.  The insulin receptor. A multifunctional protein.

Authors:  J M Olefsky
Journal:  Diabetes       Date:  1990-09       Impact factor: 9.461

7.  The role of the insulin-like growth factor I receptor in the transformation by simian virus 40 T antigen.

Authors:  B Valentinis; P L Porcu; K Quinn; R Baserga
Journal:  Oncogene       Date:  1994-03       Impact factor: 9.867

8.  Insulin-resistant MDA-MB231 human breast cancer cells contain a tyrosine kinase inhibiting activity.

Authors:  A Costantino; G Milazzo; F Giorgino; P Russo; I D Goldfine; R Vigneri; A Belfiore
Journal:  Mol Endocrinol       Date:  1993-12

Review 9.  Insulin action and the insulin signaling network.

Authors:  B Cheatham; C R Kahn
Journal:  Endocr Rev       Date:  1995-04       Impact factor: 19.871

10.  Early body size and subsequent weight gain as predictors of breast cancer incidence (Iowa, United States).

Authors:  D Barnes-Josiah; J D Potter; T A Sellers; J H Himes
Journal:  Cancer Causes Control       Date:  1995-03       Impact factor: 2.506
View more
  31 in total

Review 1.  Inhibitors of insulin-like growth factor signaling: a therapeutic approach for breast cancer.

Authors:  Deepali Sachdev; Douglas Yee
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-01       Impact factor: 2.673

Review 2.  Early drug development of inhibitors of the insulin-like growth factor-I receptor pathway: lessons from the first clinical trials.

Authors:  Jordi Rodon; Victoria DeSantos; Robert Jean Ferry; Razelle Kurzrock
Journal:  Mol Cancer Ther       Date:  2008-09       Impact factor: 6.261

Review 3.  Novel applications of COX-2 inhibitors, metformin, and statins for the primary chemoprevention of breast cancer.

Authors:  Darren Micallef; Sarah Micallef; Pierre Schembri-Wismayer; Jean Calleja-Agius
Journal:  J Turk Ger Gynecol Assoc       Date:  2016-12-01

4.  Diabetes, physical activity and breast cancer among Hispanic women.

Authors:  Maureen Sanderson; Gerson Peltz; Adriana Perez; Matthew Johnson; Sally W Vernon; Maria E Fernandez; Mary K Fadden
Journal:  Cancer Epidemiol       Date:  2010-06-29       Impact factor: 2.984

5.  Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project.

Authors:  Marilyn L Kwan; Wendy Y Chen; Candyce H Kroenke; Erin K Weltzien; Jeannette M Beasley; Sarah J Nechuta; Elizabeth M Poole; Wei Lu; Michelle D Holmes; Charles P Quesenberry; John P Pierce; Xiao Ou Shu; Bette J Caan
Journal:  Breast Cancer Res Treat       Date:  2011-12-21       Impact factor: 4.872

6.  Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer.

Authors:  Kirsten Erickson; Ruth E Patterson; Shirley W Flatt; Loki Natarajan; Barbara A Parker; Dennis D Heath; Gail A Laughlin; Nazmus Saquib; Cheryl L Rock; John P Pierce
Journal:  J Clin Oncol       Date:  2010-11-29       Impact factor: 44.544

7.  Type 2 diabetes mellitus and prognosis in early stage breast cancer women.

Authors:  Muhammet Ali Kaplan; Zafer Pekkolay; Mehmet Kucukoner; Ali Inal; Zuhat Urakci; Hamza Ertugrul; Recai Akdogan; Ugur Firat; Ismail Yildiz; Abdurrahman Isikdogan
Journal:  Med Oncol       Date:  2011-11-15       Impact factor: 3.064

Review 8.  Chemoprevention of hormone receptor-negative breast cancer: new approaches needed.

Authors:  Iván P Uray; Powel H Brown
Journal:  Recent Results Cancer Res       Date:  2011

9.  Improving health engagement and lifestyle management for breast cancer survivors with diabetes.

Authors:  Rebecca A Shelby; Caroline S Dorfman; Sarah S Arthur; Hayden B Bosworth; Leonor Corsino; Linda Sutton; Lynda Owen; Alaattin Erkanli; Francis Keefe; Cheyenne Corbett; Gretchen Kimmick
Journal:  Contemp Clin Trials       Date:  2020-04-11       Impact factor: 2.226

10.  Serum HER-2 concentration is associated with insulin resistance and decreases after weight loss.

Authors:  José Manuel Fernández-Real; Javier A Menendez; Gema Frühbeck; José María Moreno-Navarrete; Alejandro Vazquez-Martín; Wifredo Ricart
Journal:  Nutr Metab (Lond)       Date:  2010-02-25       Impact factor: 4.169
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.